Mycophenolate mofetil in the treatment of retroperitoneal fibrosis
β Scribed by Fareeha Khalil; M. A. Mir; Rocco C. Venuto
- Publisher
- Springer
- Year
- 2008
- Tongue
- English
- Weight
- 121 KB
- Volume
- 27
- Category
- Article
- ISSN
- 0770-3198
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Paraneoplastic pemphigus (PNP) is a rare autoimmune blistering disease with circulating antibodies that bind the cell surface of the epidermis and other non-stratifying epithelia, and immunoprecipitate a complex of four or five proteins (250 kDa, 230 kDa, 210 kDa, 190 kDa and occasional
## Background: Activated t and b lymphocytes are the predominant inflammatory cells in atopic eczema (ae) lesions. mycophenolic acid, the active form of mycophenolate mofetil (mmf), blocks the proliferative responses of t and b lymphocytes. ## Objectives: In this pilot study, we examined the effi
## Objective: To examine the safety of mycophenolate mofetil (mmf) for remission maintenance in patients with wegener's granulomatosis (wg) who had been treated with daily cyclophosphamide (cyc) and glucocorticoids to induce remission. ## Methods: Fourteen patients were treated for active wg usin